A Human Immunodeficiency Virus Superinfection Diagnosed in a Patient on Intramuscular Long-acting Combination of Cabotegravir and Rilpivirine
✅ Just Accepted
🆓 Freely Available
https://t.co/fCiKCLHbwJ
People with HIV who have advanced HIV disease and can't take oral ART (for whatever reason) are at high risk of OIs, cancers, and death.
Injectable CAB-RPV can be literally lifesaving--which is why this change to the @IAS_USA guidelines is so important. https://t.co/1mml1VzT8u
At our first ever CAB Meeting in 2021, one of our CAB members raised a concern about lack of research on ARV dosing in people living HIV.
Well, we listened….
Introducing: The ReDOSE Study
#CAB2023
Was honoured to present our team’s work at the International Workshop on HIV & Aging this week in Washington, DC. So incredible to hear from people with lived experience, researchers and clinicians on the work being done in this field across the world #HIVAging
Could you use tips on how to manage menopause while living with HIV?
https://t.co/dXmGLPJgHt
Menopoz & You offers reliable information to help guide you through this important life transition. Read online or order print copies delivered to you for free! #menopoz#menopositivite
Interesting paper showing higher odds of depression (OR 3.6) and suicidality (OR 4.7) for people taking INSTIs compared to other ARVs. Adverse drug reactions are important and need to be reported, especially for newer ARVs
❕Publication Alert❕
Check out this recently accepted literature review and meta-analysis written by BCC3 trainees @t_povshedna and @ShaydaSwann on the global prevalence of chronic pain in women living with HIV!
https://t.co/OK1HhsCje6
Excellent session at #IAS on injectable ARVs as the newest "game changer" in HIV care. But discouraging to see that only two of the countries with registrations for CAB/RPV LA are in Africa. Health equity needs to be at the forefront of implementation of injectable ARVs.
Exciting to be present at the unveiling of the REPRIEVE trial results at #IAS. Strong evidence for statins as primary prevention in people with HIV of low to moderate ASCVD risk. Most interesting part - effect was larger than that of just lowering LDL
https://t.co/WFa7Flc2T9
Are you 65 or older and living with HIV?
We are interested to know what healthy aging means to you.
We are conducting a study, evaluating a questionnaire call the “Healthy Aging Score”, to determine whether this is a good tool for measuring how well someone is aging with HIV.
This is unbelievable!
Kurt Wüthrich, an 84-year-old, Swiss, male scientist, who won the Nobel Prize in 2002 claims that "as a male scientist" he has "a feeling of discrimination."
He said this during the 72nd Lindau Nobel Laureate Meeting on a panel that had four old, male scientists including him and an old, male moderator. (It was literally a susage fest!)
When Science Magazine asked him to elaborate on the kind of discrimnation he faced, "Wüthrich said he did not feel personally discriminated against as an individual at the event but thought that all men attendees faced discrimination while women were tokenized."
Here's an example of the discrimination Kurt Wüthrich, a Nobel Prize winner, gave:
In group photos of laureates, women laureates were asked to stand in front while male scientists like him were told to stand behind them 🤦😂😭
This makes him feel "horrible" because asking women laureates to stand in front is "ridiculous, fully ridiculuous."
A young scholar countered Wüthrich's childish tantrum and the moderator tried to shut her up.
For reference, here's a comparison:
Nobel Prizes won:
By men: 892
By women: 60
Speakers invited to this year's Lindau meeting:
Men: 34
Women: 5
------
A couple of observations:
1. The feeling among men that gender equality is somehow a form of discrimination against them is not limited to incels (involuntary celibates) on the internet.
Male Nobel Prize winners can feel the same way too.
2. Many young scholars and scientists are still playing the "prestige" game: do a PhD in a "prestigious" university, do a postdoc in a "prestigious" lab, go to "prestigious" meetings like Lindau.
Playing the prestige game takes a lot of toll on one's mental health and personal relationships. The worst part is make you feel extremely insecure.
No amount of external validation, not even a Nobel Prize, will help you overcome your insecurities.
This week, Charity Mudhikwa discusses her work examining the prevalence of everyday racial discrimination among racialized #women in British Columbia and the associations it may have with sexual pleasure.
Read more here: https://t.co/MvUsx3tKT6
Also on Wed 14.00-15.30, I’ll be co-hosting a symposium on #HIV & menopause. Speakers inc. @susancolehaley@Juddy14536289@ElizabethKingMD Tafadzwa Madanhire from @ThruZim Anna Hachfeld from WAVE @EACSociety & showing of Bearded & Flushed https://t.co/tDgtNjxJfK 4/4
A great piece with @DrJenGunter on the @CBCTheNational about #menopause.
Bottom line is we need to do a much better job empowering women with information about their own health.
In order to do that we need more research on #WomensHealth.
Because women's health matters.
F/u of ADVANCE in @CIDJournal shows that switching to TDF/3TC/DTG leads to weight reduction if on baseline TAF/FTC+DTG, but weight increase if on TDF/FTC/EFV. Further evidence that TDF suppresses weight, in particular when combined with EFV.
https://t.co/htEtAkLpWS